CD8A and vitiligo: Collectively, our findings identify lactate as a critical driver of CD8<sup>+</sup> T cell pathogenicity in vitiligo through H3K9la-mediated epigenetic reprogramming, highlighting lactate metabolism and lactylation as potential therapeutic targets.